User login

U.S., TPP Countries Mull Compromise On Biologics Data Exclusivity

August 6, 2015 at 8:07 PM
LAHAINA, Hawaii - The United States and other Trans-Pacific Partnership (TPP) countries scrambled here to find a compromise on the controversial issue of data exclusivity for biologic drugs that would appease Australia's demand that a final deal not require a change to its domestic law on this issue. Australia's law provides five years of data exclusivity for all medicines and does not have specific provisions for biologics. The compromise proposal under discussion appears to involve setting a base period of...

Not a subscriber? Sign up for 30 days free access to exclusive, behind-the-scenes reporting on trade policy in the Biden era.